Back to overview

Immunotherapy. Open label Phase I/II study (GMP)

Applicant Mölling Karin
Number 64208
Funding scheme NRP 37 Somatic Gene Therapy
Research institution Institut für Medizinische Virologie Universität Zürich
Institution of higher education University of Zurich - ZH
Main discipline Molecular Biology
Start/End 01.01.2001 - 31.12.2001
Approved amount 120'000.00
Show all

Keywords (1)


Responsible applicant and co-applicants